Global Short-acting EPO Drugs Supply, Demand and Key Producers, 2023-2029

Global Short-acting EPO Drugs Supply, Demand and Key Producers, 2023-2029

The global Short-acting EPO Drugs market size is expected to reach $ 14140 million by 2029, rising at a market growth of 5.9% CAGR during the forecast period (2023-2029).

Short-acting EPO drugs have a wide range of applications in the market, primarily used for treating anemia-related conditions such as anemia associated with chronic kidney disease and in the supportive treatment of leukemia patients. The market size is substantial and continues to grow, particularly in Asian and European regions. Sales have been on the rise, reflecting increasing patient demand and benefiting from ongoing advancements in medical technology. In the future, short-acting EPO drugs are poised for further development, potentially encompassing the treatment of more anemia-related conditions and expanding their market share through innovative therapies and market expansion efforts.

Erythropoietin is produced by interstitial fibroblasts in the kidney in close association with peritubular capillary and proximal convoluted tubule. It is also produced in perisinusoidal cells in the liver. While liver production predominates in the fetal and perinatal period, renal production is predominant during adulthood.

This report studies the global Short-acting EPO Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Short-acting EPO Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Short-acting EPO Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Short-acting EPO Drugs total production and demand, 2018-2029, (K Units)

Global Short-acting EPO Drugs total production value, 2018-2029, (USD Million)

Global Short-acting EPO Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Short-acting EPO Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Short-acting EPO Drugs domestic production, consumption, key domestic manufacturers and share

Global Short-acting EPO Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Short-acting EPO Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Short-acting EPO Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Short-acting EPO Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Johnson & Johnson, Roche, Kyowa Kirin, LG Chem, Daewoong Pharmaceutical, Wockhardt, CJ Healthcare and 3SBio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Short-acting EPO Drugs market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Short-acting EPO Drugs Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Short-acting EPO Drugs Market, Segmentation by Type
Epoetin-alfa
Epoetin-beta
Darbepoetin-alfa
Others

Global Short-acting EPO Drugs Market, Segmentation by Application
Anemia
Kidney Disorders
Others

Companies Profiled:
Amgen
Johnson & Johnson
Roche
Kyowa Kirin
LG Chem
Daewoong Pharmaceutical
Wockhardt
CJ Healthcare
3SBio
Kexing Biopharm
Harbin Pharmaceutical Group
Beijing Four Rings Bio-Pharmaceutical

Key Questions Answered

1. How big is the global Short-acting EPO Drugs market?

2. What is the demand of the global Short-acting EPO Drugs market?

3. What is the year over year growth of the global Short-acting EPO Drugs market?

4. What is the production and production value of the global Short-acting EPO Drugs market?

5. Who are the key producers in the global Short-acting EPO Drugs market?